Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2013-08-16
Original SEC Filing: Click here
Webplus: SVA/20130816/6-K/2_EX-99.1/000.htm SEC Original: v353186_ex99-1.htm
Sinovac Schedules 2013 Annual Meeting of Shareholders BEIJING, July 19, 2013 — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2013 Annual Meeting of Shareholders on Wednesday, August 21, 2013 at 9:00 a.m. Beijing Time. The meeting will be held at No. 39 Shangdi Xi Road, Haidian District,
Webplus: SVA/20130816/6-K/3_EX-99.2/000.htm SEC Original: v353186_ex99-2.htm
Sinovac to Host Conference Call to Report Second Quarter 2013 Unaudited Financial Results BEIJING, July 31, 2013 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2013, after market closes on Tuesday, August 13, 2013 EDT. The Company
Webplus: SVA/20130816/6-K/4_EX-99.3/000.htm SEC Original: v353186_ex99-3.htm
Sinovac Reports Unaudited Second Quarter 2013 Financial Results – Conference call scheduled for Wednesday, August 14, 2013 at 8:00 AM EDT BEIJING, Aug. 13, 2013 /PRNewswire/ — Sinovac Biotech Ltd. ( SVA ), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2013. Second
Webplus: SVA/20130816/6-K/1/000.htm SEC Original: v353186_6k.htm
Company Information:
Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2013-08-16CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.